Foundation for Innovative New Diagn: federal grants and contributions: 1 agreements; $40.0M value; 1 departments; 0 programs.
Assay record ASY-CA-18AU2QB0A2 · Cite as: Assay Systems, “Foundation for Innovative New Diagn: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/foundation-for-innovative-new-diagn/
This project builds on Canada’s funding to the Foundation for Innovative New Diagnostics (FIND) during COVID-19. The initial project aims at accelerate the roll-out of safe, affordable, and effective COVID-19 diagnostics in Low- and Lower-Middle Income Countries. This project supports FIND in using testing technologies developed during COVID-19 to expand the range of diseases detected with a single test. This includes other respiratory diseases, sexually transmitted infections, and Human papillomavirus (HPV)-based screening for cervical cancer. The project aims to increase testing for the most
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.